From: Novel human partner cell line for immortalisation of rare antigen-specific B cells in mAb development
Event
Success rate,
Hybridisation
100
(%) of attempts
Stable hybrids
48
(%) of hybridised
Ig producing hybrids
23
(%) of stable hybrids